000			02142 a2200589 4500
005			20250517034053.0
264		0	_c20160321
008			201603s 0 0 eng d
022			_a1592-8721
024	7		_a10.3324/haematol.2015.125849 _2doi
040			_aNLM _beng _cNLM
100	1		_aZeidner, Joshua F
245	0	0	_aRandomized multicenter phase II study of flavopiridol (alvocidib), cytarabine, and mitoxantrone (FLAM) versus cytarabine/daunorubicin (7+3) in newly diagnosed acute myeloid leukemia. _h[electronic resource]
260			_bHaematologica _cSep 2015
300			_a1172-9 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage
650	0	4	_aCytarabine _xadministration & dosage
650	0	4	_aDaunorubicin _xadministration & dosage
650	0	4	_aDisease-Free Survival
650	0	4	_aFemale
650	0	4	_aFlavonoids _xadministration & dosage
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aLeukemia, Myeloid, Acute _xdiagnosis
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMitoxantrone _xadministration & dosage
650	0	4	_aPiperidines _xadministration & dosage
650	0	4	_aSurvival Rate
700	1		_aFoster, Matthew C
700	1		_aBlackford, Amanda L
700	1		_aLitzow, Mark R
700	1		_aMorris, Lawrence E
700	1		_aStrickland, Stephen A
700	1		_aLancet, Jeffrey E
700	1		_aBose, Prithviraj
700	1		_aLevy, M Yair
700	1		_aTibes, Raoul
700	1		_aGojo, Ivana
700	1		_aGocke, Christopher D
700	1		_aRosner, Gary L
700	1		_aLittle, Richard F
700	1		_aWright, John J
700	1		_aDoyle, L Austin
700	1		_aSmith, B Douglas
700	1		_aKarp, Judith E
773	0		_tHaematologica _gvol. 100 _gno. 9 _gp. 1172-9
856	4	0	_uhttps://doi.org/10.3324/haematol.2015.125849 _zAvailable from publisher's website
999			_c24945043 _d24945043